Regeneron Pharmaceuticals Inc. (REGN) Financial Statements (2024 and earlier)

Company Profile

Business Address 777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
State of Incorp. NY
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,8457,7425,6953,5873,2142,810
Cash and cash equivalents2,7303,1062,8862,1941,6181,468
Short-term investments8,1154,6362,8091,3931,5971,342
Receivables5,6675,3296,0373,1122,3611,950
Inventory, net of allowances, customer advances and progress billings2,5812,4021,9511,9171,4161,151
Inventory2,5812,4021,9511,9171,4161,151
Other undisclosed current assets3874113321,164699536
Total current assets:19,47915,88414,0159,7797,6896,448
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 606620631646 
Operating lease, right-of-use asset 78    
Property, plant and equipment     2,8902,576
Long-term investments and receivables5,3976,5926,8383,1363,2571,755
Long-term investments5,3976,5926,8383,1363,2571,755
Intangible assets, net (including goodwill)1,039916    
Intangible assets, net (excluding goodwill)1,039916    
Restricted cash and investments8     
Deferred income tax assets2,5751,724877859824
Other noncurrent assets444336223168145127
Other undisclosed noncurrent assets3,4553,1432,8512,576 829
Total noncurrent assets:13,60113,33011,4207,3847,1165,287
TOTAL ASSETS:33,08029,21525,43517,16314,80511,735
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,3582,0742,2071,5221,087772
Taxes payable326204921
Employee-related liabilities441466344262
Accounts payable607589564476 218
Accrued liabilities 1,2851,135384330301165
Other undisclosed accounts payable and accrued liabilities 466350492231392107
Deferred revenue459478442 592
Debt   720   
Other liabilities    122  
Contract with customer, liability453
Other undisclosed current liabilities6075895641,053418218
Total current liabilities:3,4233,1413,9332,6972,0971,443
Noncurrent Liabilities
Long-term debt and lease obligation2,7032,7011,9802,696714 
Long-term debt, excluding current maturities1,9831,9811,9801,979  
Finance lease, liability720720 717714
Liabilities, other than long-term debt981708754 905826
Deferred revenue1277073 619
Contract with customer, liability464
Other liabilities854638680 286362
Other undisclosed noncurrent liabilities    745 709
Total noncurrent liabilities:3,6843,4092,7343,4411,6191,534
Total liabilities:7,1076,5516,6666,1383,7162,977
Equity
Equity, attributable to parent, including:25,97322,66418,76911,02511,0908,757
Treasury stock, value(12,560)(10,353)(8,261)(6,613)(740)(396)
Additional paid in capital11,3549,9498,0886,7164,4293,912
Accumulated other comprehensive income (loss)(81)(239)(26)2921(12)
Retained earnings27,26023,30718,96810,8937,3805,254
Other undisclosed equity, attributable to parent000000
Total equity:25,97322,66418,76911,02511,0908,757
TOTAL LIABILITIES AND EQUITY:33,08029,21525,43517,16314,80511,735

Income Statement (P&L) ($ in millions)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues13,11712,17316,0728,4977,8636,711
Cost of revenue(2,000)(1,726)(2,392)(840)(768)(434)
Cost of goods and services sold (102)(259)(457)(39)(74) 
Gross profit:11,11710,44713,6807,6587,0966,277
Operating expenses(7,070)(5,708)(4,733)(4,081)(4,886)(3,742)
Other operating income (expense), net29046280  
Other undisclosed operating income (loss)(2)(90)(46)(280)  
Operating income:4,0474,7398,9473,5772,2102,534
Nonoperating income15212037923421919
Other nonoperating income22517943629125047
Interest and debt expense(73)(59)(57)(57)(30)(28)
Other undisclosed income from continuing operations before equity method investments, income taxes    573028
Income from continuing operations before equity method investments, income taxes:4,1264,7999,2693,8102,4292,554
Other undisclosed income from continuing operations before income taxes735957   
Income from continuing operations before income taxes:4,1994,8599,3263,8102,4292,554
Income tax expense(246)(520)(1,251)(297)(313)(109)
Income from continuing operations:3,9544,3388,0753,5132,1162,444
Income before gain (loss) on sale of properties:8,0753,5132,1162,444
Net income available to common stockholders, diluted:3,9544,3388,0753,5132,1162,444

Comprehensive Income ($ in millions)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income:3,9544,3388,0753,5132,1162,444
Other comprehensive income (loss)158(213)(56)  (6)
Other undisclosed comprehensive income      
Comprehensive income:4,1124,1268,0203,5132,1162,438
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   833 
Comprehensive income, net of tax, attributable to parent:4,1124,1268,0203,5212,1492,438

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: